alexa Development and Validation of High Performance Thin Layer Chromatography for Determination of Esomeprazole Magnesium in Human Plasma | Open Access Journals
ISSN: 2157-7064
Journal of Chromatography & Separation Techniques
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Development and Validation of High Performance Thin Layer Chromatography for Determination of Esomeprazole Magnesium in Human Plasma

Gosavi SM* and Tayade MA

Department of Pharmaceutical Chemistry, M. G. V.’s Pharmacy College, Panchavati, Mumbai, Agra Road, Nashik- 422003, Maharashtra, India

*Corresponding Author:
Gosavi SM
Department of Pharmaceutical Chemistry
M. G. V.’s Pharmacy College, Panchavati
Mumbai, Agra Road
Nashik- 422003, Maharashtra, India
Tel: +91 253 2515620
E-mail: [email protected]

Received Date: August 04, 2016 Accepted Date: March 13, 2017 Published Date: March 20, 2017

Citation: Gosavi SM, Tayade MA (2017) Development and Validation of High Performance Thin Layer Chromatography for Determination of Esomeprazole Magnesium in Human Plasma. J Chromatogr Sep Tech 8: 360. doi: 10.4172/2157-7064.1000360

Copyright: © 2017 Gosavi SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Chromatography & Separation Techniques

Abstract

A simple, sensitive, rapid and economic high performance thin layer chromatographic method has been developed for determination of Esomeprazole magnesium in human plasma by liquid-liquid extraction. The plasma sample was extracted using chloroform. A concentration range from 200-700 ng/spot of Esomeprazole magnesium was used for calibration curve. The percent recovery of Esomeprazole magnesium was found 101.61 percent. The mobile phase constitute of ethyl acetate: methanol: ammonia (32%) (9:1: 0.5 v/v). Densiometric analysis was carried out at wavelength 301 nm. The Rf value for Esomeprazole magnesium was found 0.54 ± 0.05. The stability of Esomeprazole magnesium in human plasma was confirmed during freeze thaw cycles at -30°C, on bench top during 24 h at room temperature and post preparative for 48 h. The proposed method was validated statistically by performing recovery study for determination of Esomeprazole magnesium in human plasma by liquid-liquid extraction.

Keywords

HPTLC; Esomeprazole magnesium; Human plasma; Liquid-liquid extraction

Introduction

Esomeprazole magnesium dihydrate1 (ESO), bis(5-methoxy- 2-[(S)-[(4-methoxy-3,5dimethyl-2-pyridinyl) methyl] sulfinyl]- 1-Hbenzimidazole-1-yl) magnesium dihydrate (Figure 1) a, is a compound that inhibits gastric acid secretion. ESO is cost-effective in the treatment of gastric oesophageal reflux diseases. ESO is the S-isomer of omeprazole, the first single optical isomer proton pump inhibitor, generally provides better acid control than current racemic proton pump inhibitors and has a favorable pharmacokinetic profile relative to omeprazole. Several methods have been employed for the estimation of ESO alone and combination with other drugs such as UV and RP-HPLC methods. Literature survey reveals that many analytical methods such as UV spectrophotometric [1-4], HPLC methods [5-10], LCMS [11], HPTLC [12-14] methods are reported for determination of Esomeprazole magnesium individually as well in combination. Specific and sensitive methods based on mass spectrometry methods were reported earlier. Earlier reports on HPLC based bioanalytical estimation of esomeprazole resulted in lesser sensitivity, and high noise in the base line indicating a need to develop a more efficient, sensitive, simple and rapid method in human plasma. To access the reproducibility and wide applicability of the developed method, it was validated as per FDA guidelines [15].

chromatography-separation-techniques-Typical-densitogram

Figure 1: Typical densitogram of Esomeprazole magnesium in human plasma (300 ng/spot). Typical densitogram of Esomeprazole magnesium in human plasma (300 ng/spot).

Materials and Methods

Instrumentation

HPTLC Camag with precoated silica gel Plate 60F254 (20 cm × 10 cm) 250 μm thicknesses (E. Merck, Darmstadt, Germany) was used as stationary phase. Sample application was done by using Camag 100 μl syringe and Camag Linomat V applicator. The sample was sprayed in the form of narrow bands of 8 mm length at a constant rate 2 μl/s. Linear ascending development was carried out in 20 cm × 10 cm twin trough glass chamber (Camag, Muttenz, Switzerland). The densitometric scanning was performed by using Camag TLC scanner III supported by win CATS software (V1.4.2.8121 Camag). Evaluation of chromatogram was done by using peak areas of drug.

Chemicals

Esomeprazole magnesium (A.S Bulk drugs, Hyderabad, India), was used as such by without checking their purity. The HPLC grade methanol and Analytical Reagent grade ethyl acetate, ammonia solution, chloroform was purchased from Modern sciences, Nashik, India. Human plasma used for research work was supplied by Arpan Blood Bank, Nashik, Maharashtra, India.

Chromatographic condition

Mobile phase was selected as mixture of Ethyl acetate: methanol: ammonia solution (32%) in the ratio of (9:1:0.5 v/v/v) for the development of plates. Time for chamber saturation was optimized to 20 min. The length of chromatographic development was 70 mm. The densitometric scanning was performed at 301 nm.

Preparation of stock solution and working standard solution

Stock solutions1 mg/ml each of Esomeprazole magnesium was prepared in methanol.

Preparation of plasma sample

To 1 ml of fresh human plasma in separate 15 ml of centrifuge tubes, spiked 1 ml of drug solution from 1000 mg/ml stock solution. Wait for Cmax i.e up to Tmax of drug (1 and ½ h) to reach equilibrium concentration. 5 ml extracting solvent chloroform was then added in centrifuge tube. Tube was cycomix for 5 min and then centrifuged at 3000 for 20 min. After centrifugation process, the supernatant liquid was collected in another tube and volume make up to 10 ml with methanol. The analysis was carried on HPTLC.

Method validation

Calibration plot: The calibration plot for the HPTLC method was constructed by analysis of six solutions containing different concentrations of Esomeprazole magnesium (200-700 ng/ml). The Esomeprazole magnesium can be determined at LLOQ 2 μl/ml. In the range 200-700 ng/ml the data were best fitted by a linear equation y=mx+b, the coefficient of determination (R2) was 0.9958.

Selectivity: For selectivity, analyses of blank sample of the appropriate biological matrix (plasma) were done. Each blank sample was tested for interference, and selectivity was ensured at the lower limit of quantification (LLOQ) i.e., 200 ng/ml [16,17].

Precision: Precision was measured using a minimum of three determinations per concentration (200, 400, 600 ng/spot). Intraday precision (Repeatability) was performed by taking three different concentrations (200, 00, 600 ng/spot) covering specified range in the triplicates and were analyzed three times within a day with same operator and with same equipment. Inter day precision was determined by analyzing three different concentrations (200, 400, 600 ng/spot) in triplicates on three different days within same laboratory conditions.

Accuracy: Accuracy was determined by replicate analysis of samples containing known amounts of the analyte (200, 400, 600 ng/ spot). The study was determined by spiking known amount of standard stock to the test solution prepared from tablet formulation at three different spiking level 80%, 100%, 120% of target concentration.

Recovery: Recovery experiments was performed by comparing the analytical result for extracted samples at three concentrations (200, 400, 600 ng/spot) with unextracted standards that represent 100% recovery.

Limit of detection (LOD) and limit of quantitation (LOQ): The parameters LOD and LOQ were determined using the signal-tonoise ratio by comparing results of the test of samples with known concentrations of analyte to blank samples. The analyte concentration that produced a signal-to noise ratio of 3:1 was accepted as the LOD. The LOQ was identified as the lowest plasma concentration of the standard curve that could be quantified with acceptable accuracy, precision and variability.

Stability

Bench top stability: A Stock solution of Esomeprazole magnesium was kept at room temperature for 24 hours.

Post preparative stability: A Stock solution of Esomeprazole magnesium was kept at room temperature for 48 days.

Freeze thaw stability: The stability of low and high quality control samples were determined after three freeze thaw cycles.

Results and Discussion

Extraction Procedure Optimization One of the most difficult task during the method development was to achieve a high and reproducible recovery from the solvent, which is used for extraction of the drug (Table 1). Different solvents were tried for the extraction of from human plasma. Densitogram obtained shows the Rf at 0.52 and is shown in Figure 1. HPTLC densitogram of 200-700 ng/band was analyzed and observed 3-D view was shown in Figure 2.

chromatography-separation-techniques-Esomeprazole-magnesium

Figure 2: 3-D view of Esomeprazole magnesium 200-700 ng/band.

Sn no Solvents used Recovery
1 Acetonitrile No recovery
2 Ethyl acetate No recovery
3 Dimethyl ether No recovery
4 Chloroform 1ml 20%
5 Chloroform 2ml 40%
6 Chloroform 4ml 70-80%
7 Chloroform 5ml 90%

Table 1: Extraction procedure optimization.

Linearity

The linear plot was observed in the concentration range of 200- 700 ng/spot. Results obtained are shown in Table 2 and calibration plot obtained was shown in Figure 2.

Sn no Conc. in ng/spot Area
1 200 3197.20
2 300 4317.58
3 400 5101.51
4 500 6038.19
5 600 7014.55
6 700 7795.89

Table 2: Data of calibration curve of Esomeprazole magnesium in human plasma.

Precision

Intraday and interday precision of Esomeprazole magnesium in human plasma assures the repeatability of test results. The % RSD found was below 2. Results of intraday and interday precision were shown in Table 3 and Table 4, respectively.

Conc. in ng/spot Mean SD % RSD SE
200 3219.249
15.51388
0.48191 8.957203
400 5422.349 22.42588 0.413582 12.94797
600 7327.349 51.20786 0.698859 29.56574

Table 3: Data for intraday precision of Esomeprazole magnesium in human plasma by HPTLC method.

Conc. in ng/spot Mean SD % RSD SE
200 3280.24 51.75421 1.57762 29.88118
400 5654.73 23.75512 0.420093 13.71543
600 7675.251 95.36232 1.242465 55.05908

Table 4: Data for interday precision of Esomeprazole magnesium in human plasma by HPTLC method.

Accuracy

Accuracy was studied by standard addition method and % recovery found was within acceptable limit. Results of recovery study are shown in Table 2 and Table 4 and statistical validation is shown in Table 5.

Level of addition   Tablet conc. (ng/band) API conc. (ng/band) Total conc. In ng/spot % recovery
80% 300 240 540 95.47
300 240 540 99.19
300 240 540 100.2
100% 300 300 600 99.90
300 300 600 101.2
300 300 600 100.25
120% 300 360 660 99.80
300 360 660 100.01
300 360 660 98.59

Table 5: Data for recovery study of Esomeprazole magnesium in human plasma by HPTLC method.

Recovery

The recovery of Esomeprazole magnesium for HPTLC recovery at the three concentrations 200, 400, 600 ng/spot were found to 87.82%, 83.84%and 95.27%, respectively (Table 6).

Sn no Concentration (ng) % Recovery
1 200 87.82
2 400 83.84
3 600 95.27

Table 6: Result of recovery of Esomeprazole magnesium in human plasma.

Selectivity

Analyses of blank sample of the appropriate biological matrix (plasma) were done. Each blank sample was tested for interference, and selectivity was ensured at the lower limit quantification and chromatogram was shown in Figure 3.

chromatography-separation-techniques-Chromatogram

Figure 3: Chromatogram of Blank human plasma at 300 ng/spot.

Stability

Freeze thaw stability: The stability of low and high quality control samples were determined after three freeze thaw cycles (Table 7).

Sn no Conc. In ng/spot Recovery (%) Thaw extract
1 200 94.23
2 400 100.69
3 600 100.2

Table 7: Result of freeze thaw stability of Esomeprazole in human plasma.

Short term stock stability: A Stock solution of Esomeprazole magnesium was kept at room temperature for 24 hours (Table 8).

Sn no Conc. In ng/spot Recovery (%) Thaw extract
1 200 93.18
2 400 95.74
3 600 97.36

Table 8: Results of Bench top stability of ESO in human plasma.

Post preparative stability: A Stock solution of Esomeprazole magnesium was kept at room temperature for 48 days (Table 9).

Sn no Conc. In ng/spot Recovery (%) Thaw extract
1 200 99.173
2 400 100.5
3 600 98.40

Table 9: Results for post preparative stability of Esomeprazole in human plasma.

Conclusion

The proposed HPTLC method for the estimation of Esomeprazole magnesium in human plasma is selective and sensitive. Sensitivity of the method is suitable for handling various plasma levels of the drug. The method is economical and faster than earlier published methods. In future, we can use this method for bioequivalence study.

Acknowledgement

The authors are thankful to the Management and Principal, Dr. Rajendra S. Bhambar of M G V’s Pharmacy College, Nashik for providing necessary facilities for the research work. The authors are also thankful to Arpan Blood Bank, Nashik for providing human plasma, (A.S. Bulk Drugs, Hyderabad, India) for providing Esomeprazole Magnesium, as a gift sample for the research work.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 1062
  • [From(publication date):
    April-2017 - Jun 28, 2017]
  • Breakdown by view type
  • HTML page views : 1011
  • PDF downloads :51
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords